Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Clofazimine MeSH Descriptor Data 2025


MeSH Heading
Clofazimine
Tree Number(s)
D03.633.300.704.353
Unique ID
D002991
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D002991
Scope Note
A fat-soluble riminophenazine dye used for the treatment of leprosy. It has been used investigationally in combination with other antimycobacterial drugs to treat Mycobacterium avium infections in AIDS patients. Clofazimine also has a marked anti-inflammatory effect and is given to control the leprosy reaction, erythema nodosum leprosum. (From AMA Drug Evaluations Annual, 1993, p1619)
Entry Term(s)
B-663
G-30,320
Lamprene
N,5-Bis(4-chlorophenyl)-3,5-dihydro-3-((1-methylethyl)imino)-2-phenazinamine
Pharm Action
Anti-Inflammatory Agents
Leprostatic Agents
Registry Numbers
D959AE5USF
0
Related Numbers
2030-63-9
CAS Type 1 Name
2-Phenazinamine, N,5-bis(4-chlorophenyl)-3,5-dihydro-3-((1-methylethyl)imino)-
Public MeSH Note
74
History Note
74
Date Established
1974/01/01
Date of Entry
1999/01/01
Revision Date
2016/05/28
Clofazimine Preferred
Lamprene Narrower
B-663 Narrower
G-30,320 Narrower
page delivered in 0.142s